Axiom.iqAxiom Insights empowers nascent biotech ventures with precision-driven, data-backed strategic foresight. We specialize in providing Evidence-Based Forecasting for Biotech Startups, translating complex scientific and market data into actionable intelligence that de-risks development pathways and accelerates market entry. Our tailored insights equip innovators to navigate regulatory landscapes and secure critical funding with unparalleled confidence.
OSTOST pioneers personalized wellness solutions by leveraging cutting-edge biotechnology to unlock individual genetic blueprints. We empower our clients to truly 'Discover Your Signature Style' through bespoke insights into their unique biological makeup, guiding them toward optimal health and aesthetic choices with scientific precision and innovation.
BunzBunz specializes in advanced biotechnological solutions, providing cutting-edge platforms for secure and efficient handling of critical biological assets. We empower researchers and pharmaceutical companies to accelerate discovery and development by ensuring the integrity and viability of their most vital resources. With Bunz, you can truly "trust us with your bread," knowing your foundational science is in expert hands.
VANTORBIOTECHVANTORBIOTECH stands at the vanguard of biotechnological innovation, dedicated to pioneering advanced research and development that addresses some of humanity's most pressing health challenges. We leverage cutting-edge scientific methodologies and a deep understanding of biological systems to accelerate the discovery and translation of novel therapeutics and diagnostics, ultimately aiming to improve patient outcomes and redefine medical possibilities.
sackett analytical technologiesSackett Analytical Technologies is at the forefront of unraveling complex biological datasets. We specialize in the sophisticated analysis required to uncover hidden patterns, transforming raw information into actionable biological insights. By meticulously applying advanced methodologies, we empower researchers and biopharmaceutical companies to accelerate discovery and make data-driven decisions, truly finding patterns of biological data.
WASTEINEERSWASTEINEERS engineers biotech solutions that transform waste streams into high-value biological products, closing the loop between industry byproducts and sustainable bio-manufacturing. Combining metabolic engineering, microbial consortia design, and scalable fermentation platforms, we turn underutilized carbon and nitrogen sources into enzymes, bioplastics precursors, and specialty chemicals—delivering measurable lifecycle benefits, regulatory readiness, and cost-competitive supply for circular-economy partners.
Yohann CampilloYohann Campillo pioneers translational biotech solutions that engineer resilient, next-generation cell therapies and regenerative platforms to restore function and extend healthy life. Combining rigorous molecular engineering, scalable manufacturing know-how, and a patient-centric translational pipeline, the company turns cutting‑edge cellular science into clinically actionable products—Future Cells, Stronger Life—accelerating safe, durable treatments from lab to bedside.
BIOGRIPBIOGRIP desarrolla soluciones biotecnológicas avanzadas para potenciar el rendimiento y la recuperación del movimiento humano mediante materiales y dispositivos inteligentes que interactúan con tejidos y sistemas mecánicos. Combinando investigación biomolecular, bioingeniería y sensores integrados, ofrecemos productos clínicamente validados que mejoran la adherencia, la funcionalidad y la comodidad en rehabilitación y deportes —Tecnología que da vida a tus movimientos—, respaldados por ensayos y colaboraciones con centros médicos y atletas de alto rendimiento.
TYPNOTYPNO pioneers precision-driven biotech solutions that translate complex genomic and proteomic insights into actionable therapies and diagnostics. Combining advanced computational biology, proprietary assay platforms, and rigorous translational pipelines, TYPNO accelerates reliable, clinic-ready discoveries—delivering scalable, reproducible results that shorten development timelines and de‑risk commercialization for partners and patients alike.